Covid waves, Gene therapy for haemophilia B, New uses for old drugs

Covid waves, Gene therapy for haemophilia B, ...

Up next

What's driving the outbreak of meningitis among students?

More than 30,000 people are being contacted in the Canterbury area regarding the outbreak of bacterial meningitis in Kent. Two people have died, and others are seriously ill. James Gallagher speaks with immunologist Sir Andrew Pollard about the disease, and finds out what could h ...  Show more

What causes vaccine hesitancy?

There have been nearly 200 cases of measles in the UK so far this year.Measles can be prevented with vaccines - but the proportion of children being immunised is declining across the UK, particularly in parts of London.James visits Hackney, which has one of the lowest vaccination ...  Show more

Recommended Episodes

The silence of the genes
Discovery

In summer of 2019 NICE approved the use of a completely new class of drugs: the gene silencers. These compounds are transforming the lives of families who have rare debilitating – and sometimes fatal - diseases such as amyloidosis and porphyria. James Gallagher, BBC Health and Sc ...  Show more

Prognosis, a New Show From Bloomberg
Prognosis: Misconception

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ...  Show more

Talk Evidence - GP data, excess mortality and FDA approval
Medicine and Science from The BMJ

In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM. Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at dif ...  Show more

Old Drugs, New Disease
Chasing Life

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ...  Show more